Product
Potassium Canrenoate
1 clinical trial
1 indication
Indication
Brain-dead Organ DonorsClinical trial
Evaluation of the Hemodynamic Stability of Potassium Canrenoate in Brain-dead Organ Donors: Randomized Controlled Clinical TrialStatus: Recruiting, Estimated PCD: 2024-02-26